Home/Directory/Industry / Vertical AI/BenevolentAI

BenevolentAI

AI and machine learning platform with a knowledge graph for life sciences research.

Venture Funded$292MSeries CWoodford Investment ManagementSV Health InvestorsMorningside Ventures

drug discoverybiomedical dataAI platformpharmaceutical R&D

About

BenevolentAI is a platform that brings together science and technology teams to apply AI and machine learning to life sciences. The platform is built on a knowledge graph and proprietary ontologies developed over a decade of investment. It supports scientists and executives in leveraging AI for their work. The company also powers Qor, described as an always-on strategic function for biopharma decision makers and life science consultancies.

Read from benevolent.ai on 2026-08-26. We describe what the vendor states; we do not audit it.

Enterprise Readiness

from cataloged data

65/100 · Strong

Security & ComplianceNot disclosed

No compliance certifications listed

Deployment FlexibilityStrong

Flexible deployment: Cloud, Hybrid

Integration DepthStrong

8 documented integrations

Proven AdoptionPartial

5 documented use cases

Company MaturityStrong

Founded 2013 · Series C

Composite of public compliance, deployment, integration, adoption, and company signals. “Not disclosed” reflects gaps in available data, not a vendor deficiency.

Enterprise Use Cases

AI-driven drug target identification

Biomedical data integration and analysis

Predictive modeling for clinical trials

Accelerated R&D decision making

Regulatory compliance management

Integrations

AWSMicrosoft AzureGoogle CloudSalesforceTableauSnowflakeDatabricksJupyter

How BenevolentAI compares

Tool	Readiness	Pricing	Deployment	Compliance	Integrations
BenevolentAI	65 · Strong	Enterprise	Cloud, Hybrid	—	8
Aidoc	70 · Strong	Enterprise	Cloud, On-Premise, Hybrid	—	8
Enlitic	Not scored	Enterprise	Cloud, On-Premise, Hybrid	—	6
Babylon Health	Not scored	Enterprise	Cloud, Hybrid	—	8

Peers from the same category, ranked by Enterprise Readiness. Readiness is a composite of cataloged compliance, deployment, integration, adoption, and company signals.

Frequently Asked Questions

What is BenevolentAI used for?

BenevolentAI is aI and machine learning platform with a knowledge graph for life sciences research. It is commonly used for ai-driven drug target identification, biomedical data integration and analysis, predictive modeling for clinical trials, and accelerated r&d decision making.

Is BenevolentAI free, and how is it priced?

BenevolentAI uses enterprise pricing, typically a custom quote based on seats, usage, and requirements. Contact the vendor for a quote.

How can BenevolentAI be deployed?

BenevolentAI supports Cloud and Hybrid deployment. It is delivered as a cloud-hosted service.

What does BenevolentAI integrate with?

BenevolentAI documents 8 integrations, including AWS, Microsoft Azure, Google Cloud, Salesforce, Tableau, and Snowflake.

When was BenevolentAI founded?

BenevolentAI was founded in 2013 and has raised $292M in funding.

Is BenevolentAI enterprise-ready?

Based on cataloged data, BenevolentAI has an Enterprise Readiness score of 65/100 (Strong tier), derived from its compliance, deployment, integration, adoption, and company-maturity signals.

Quick Facts

PricingEnterprise

DeploymentCloud, Hybrid

Founded2013

Funding$292M

CategoryIndustry / Vertical AI

Procurement

Evaluating vendors like this one?

The Enterprise AI RFI/RFP asks the security, governance, and lock-in questions sales decks skip.

See the template — RFI $299 / RFP $699 →

Is this your product?

Claiming is free and lets you correct your listing's data. Upgrade to Enhanced ($199/yr) for a vendor-maintained mark, a richer profile, and lead routing.